跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-LISINOPRIL lisinopril 5mg (as dihydrate) tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APO-LISINOPRIL lisinopril 5mg (as dihydrate) tablet blister pack
Approved
STANDARD
APO-LISINOPRIL lisinopril 5mg (as dihydrate) tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f2504af8e1b98044
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
f2504af8e1b98044
Product Name
APO-LISINOPRIL lisinopril 5mg (as dihydrate) tablet blister pack
Artg Id
213393
Artg Name
APO-LISINOPRIL lisinopril 5mg (as dihydrate) tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2013-10-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/52629d5ed8995c373e204e95edb661ca.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/77f1504bce834ba3c4d8409943306f7e.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f2504af8e1b98044
Type
Standard
Back to TGA Approvals